Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease

被引:0
|
作者
Duman, BS
Türkoglu, C
Akpinar, B
Güden, M
Vertii, A
Dak, E
Çagatay, P
Günay, D
Büyükdevrim, AS
机构
[1] Kadir Has Univ, Sch Med, Dept Med Biol & Genet, TR-80810 Istanbul, Turkey
[2] Kadir Has Univ, Sch Med, Dept Cardiol, TR-80810 Istanbul, Turkey
[3] Kadir Has Univ, Sch Med, Dept Heart & Vasc Surg, TR-80810 Istanbul, Turkey
[4] Istanbul Univ, Cerrahpasa Med Sch, Dept Biostat, Istanbul, Turkey
[5] Florence Nightingale Hosp, Biochem Lab, Istanbul, Turkey
[6] Florence Nightingale Hosp, Dept Diabetol & Metab Disorders, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Lipoprotein lipase (LPL) plays a central role in lipid metabolism, hydrolyzing triglyceride in chylomicrons and very-low-density lipoproteins. The PvuII polymorphic variant of LPL gene is common and might affect risk of coronary artery disease (CAD). Objective.-Our aim was to determine whether LPL-PvuII polymorphism can be considered to be an independent risk factor or a predictor for CAD in Turkish subjects. Design.-We used polymerase chain reaction and restriction enzyme digestion to determine the distribution of the previously described C-->T transition that causes a PvuII polymorphism in intron 6 among healthy blood donors of Turkish origin and among angiographically confirmed CAD patients with comparable ethnic backgrounds. Results.-For the PvuII genotypes, within the CAD group (n = 80), the +/- genotype was found in 39 individuals (48.8%), whereas 25 (31.3%) carried the +/+ genotype, and 14 (17.5%) carried the -/- genotype. Within the control group (n = 49), the -/- genotype was found in 19 individuals (38.8%), 16 (32.7%) carried the +/- genotype, and 14 (28.6%) carried the +/+ genotype. The genotype frequency distribution was significantly different (P = .049) in the CAD and control study groups. The most frequent genotype among CAD patients was +/-; this genotype was more frequent in patients than in control subjects. However, the -/- genotype was more prevalent in the control group. Lipoprotein lipase-PvuII polymorphism was found to be associated with fasting total cholesterol and low-density lipoprotein cholesterol levels. The +/+ genotype was found to have higher levels of total cholesterol and low-density lipoprotein cholesterol in both the CAD and control groups. Conclusion.-There was a difference in the distribution of LPL-PvuII genotypes between the healthy subjects and the patients with CAD. Lipoprotein lipase-PvuII polymorphisms were not detected as independent risk factors for CAD in this study group, but had associations with lipid levels.
引用
收藏
页码:869 / 874
页数:6
相关论文
共 50 条
  • [1] Study of the participation of Lipoprotein Lipase gene polymorphism in coronary artery disease
    Asal, Ghufran Mohammed Hussein
    Al-Janabi, Lamees M.
    Hussein, Nibras Yahya
    EURASIAN CHEMICAL COMMUNICATIONS, 2022, 4 (07): : 590 - 597
  • [2] Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia
    Pasalic, D
    Sertic, J
    Kunovic, B
    Milicevic, Z
    Pasic, A
    Zrinski-Topic, R
    Ferencak, G
    Stavljenic-Rukavina, A
    CROATIAN MEDICAL JOURNAL, 2001, 42 (05) : 517 - 522
  • [3] Lipoprotein lipase gene mutations in coronary artery disease
    Minnich, A
    Baloukas, J
    Roederer, G
    Lussier-Cacan, S
    Davignon, J
    Genest, J
    CANADIAN JOURNAL OF CARDIOLOGY, 1998, 14 (05) : 711 - 716
  • [4] Associations of three lipoprotein lipase gene polymorphisms, lipid profiles and coronary artery disease
    Daoud, Mohamed S.
    Ataya, Farid S.
    Fouad, Dalia
    Alhazzani, Amal
    Shehata, Afaf I.
    Al-Jafari, Abdulaziz A.
    BIOMEDICAL REPORTS, 2013, 1 (04) : 573 - 582
  • [5] Association of lipoprotein lipase gene polymorphisms with coronary artery disease
    Anderson, JL
    King, GJ
    Bair, TL
    Elmer, SP
    Muhlestein, JB
    Habashi, J
    Mixson, L
    Carlquist, JF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (04) : 1013 - 1020
  • [6] THE HINDIII POLYMORPHISM OF LIPOPROTEIN LIPASE GENE AND LIPID PROFILE IN CAUCASIAN POPULATION OF WEST SIBERIA
    Shakhtshneider, E.
    Ragino, Y.
    Polonskaya, Y.
    Kashtanova, E.
    Nikitin, Y.
    Malyutina, S.
    Voevoda, M.
    ATHEROSCLEROSIS, 2014, 235 (02) : E100 - E101
  • [7] Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease
    Ferencak, G
    Pasalic, D
    Grskovic, B
    Cheng, S
    Fijal, B
    Sesto, M
    Skodlar, J
    Rukavina, AS
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) : 541 - 546
  • [8] Lipoprotein lipase gene PvuII polymorphism serum lipids and risk for coronary artery disease: Meta-analysis
    Cagatay, Penbe
    Susleyici-Duman, Belgin
    Ciftci, Cavlan
    DISEASE MARKERS, 2007, 23 (03) : 161 - 166
  • [9] Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans
    Larifla, Laurent
    Armand, Christophe
    Bangou, Jacqueline
    Blanchet-Deverly, Anne
    Numeric, Patrick
    Fonteau, Christiane
    Michel, Carl-Thony
    Ferdinand, Severine
    Bourrhis, Veronique
    Velayoudom-Cephise, Fritz-Line
    PLOS ONE, 2017, 12 (07):
  • [10] Relationship between a novel polymorphism of lipoprotein lipase gene and coronary heart disease
    Su, ZG
    Zhang, SZ
    Hou, YP
    Zhang, L
    Liao, LC
    Xiao, CY
    CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 677 - 680